Recombinant multi-species HELIOS/IKZF2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HELIOS/IKZF2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the Ikaros family of zinc-finger proteins. Three members of this protein family (Ikaros, Aiolos and Helios) are hematopoietic-specific transcription factors involved in the regulation of lymphocyte development. This protein forms homo- or hetero-dimers with other Ikaros family members, and is thought to function predominantly in early hematopoietic development. Multiple transcript variants encoding different isoforms have been found for this gene, but the biological validity of some variants has not been determined. [provided by RefSeq, Jul 2008]
The Alternative Names of target: A730095J18Rik,ANF1A2,HELIOS,Helios,IKZF2,Ikaros family zinc finger protein 2,Ikzf2,ZNF1A2,ZNFN1A2,Zfpn1a2,Zinc finger protein Helios,Znfn1a2

Target products collectionGo to HELIOS/IKZF2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T81569-Ag-1/ GM-Tg-hg-T81569-Ag-2 Human HELIOS/IKZF2 protein Human
GM-Tg-rg-T81569-Ag-1/ GM-Tg-rg-T81569-Ag-2 Rat HELIOS/IKZF2 protein Rat
GM-Tg-mg-T81569-Ag-1/ GM-Tg-mg-T81569-Ag-2 Mouse HELIOS/IKZF2 protein Mouse
GM-Tg-cynog-T81569-Ag-1/ GM-Tg-cynog-T81569-Ag-2 Cynomolgus/Rhesus macaque HELIOS/IKZF2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T81569-Ag-1/ GM-Tg-felg-T81569-Ag-2 Feline HELIOS/IKZF2 protein Feline
GM-Tg-cang-T81569-Ag-1/ GM-Tg-cang-T81569-Ag-2 Canine HELIOS/IKZF2 protein Canine
GM-Tg-bovg-T81569-Ag-1/ GM-Tg-bovg-T81569-Ag-2 Bovine HELIOS/IKZF2 protein Bovine
GM-Tg-equg-T81569-Ag-1/ GM-Tg-equg-T81569-Ag-2 Equine HELIOS/IKZF2 protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T81569-Ag-1/ GM-Tg-hg-T81569-Ag-2; GM-Tg-rg-T81569-Ag-1/ GM-Tg-rg-T81569-Ag-2;
GM-Tg-mg-T81569-Ag-1/ GM-Tg-mg-T81569-Ag-2; GM-Tg-cynog-T81569-Ag-1/ GM-Tg-cynog-T81569-Ag-2;
GM-Tg-felg-T81569-Ag-1/ GM-Tg-felg-T81569-Ag-2; GM-Tg-cang-T81569-Ag-1/ GM-Tg-cang-T81569-Ag-2;
GM-Tg-bovg-T81569-Ag-1/ GM-Tg-bovg-T81569-Ag-2; GM-Tg-equg-T81569-Ag-1/ GM-Tg-equg-T81569-Ag-2
Products Name HELIOS/IKZF2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name HELIOS/IKZF2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine HELIOS/IKZF2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.